GC
Deborah Ann Miller, Ph.D., J.D., is the Chief Legal Officer and Secretary at Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company focused on targeted cancer therapies, a role she has held since June 2021.[[1]](https://fintool.com/app/research/companies/NUVL/people/deborah-miller)[[6]](https://investors.nuvalent.com/our-team)[[8]](https://investors.nuvalent.com/deb-miller) At 49 years old, she brings over 20 years of experience in biopharma legal and intellectual property matters, spanning early discovery to litigation.[[1]](https://fintool.com/app/research/companies/NUVL/people/deborah-miller)
Miller earned a B.A. in chemistry from Swarthmore College, an M.M.Sc. from Harvard Medical School, a Ph.D. in biological chemistry and molecular pharmacology from Harvard University, and a J.D. from Suffolk University Law School.[[1]](https://fintool.com/app/research/companies/NUVL/people/deborah-miller) Her career highlights include serving as Senior Vice President, Deputy General Counsel, and Chief IP Counsel at Sumitomo Dainippon Pharma America (2020–2021) and Sunovion Pharmaceuticals (2017–2020), where she led legal and IP services for North American operations; Vice President, Deputy General Counsel, and Chief Patent Counsel at Infinity Pharmaceuticals (2010–2017), building the IP group and supporting licensing and financings; and earlier roles at Sepracor and Nutter McClennen & Fish LLP.[[1]](https://fintool.com/app/research/companies/NUVL/people/deborah-miller)[[5]](https://www.prnewswire.com/news-releases/nuvalent-announces-business-and-program-highlights-and-reports-second-quarter-2021-financial-results-301370838.html) Recently, as a corporate insider, she sold 6,902 shares for $676,157 on January 5–6, 2026, and acquired 17,500 RSUs on January 7, 2026, retaining direct ownership of 59,634 shares.[[2]](https://www.ainvest.com/news/nuvalent-miller-deborah-ann-buys-sells-shares-market-fluctuations-2601/)[[3]](https://www.sahmcapital.com/news/content/nuvalent-chief-legal-officer-deborah-ann-miller-reports-disposal-of-common-shares-2026-01-06)[[4]](https://www.investing.com/news/insider-trading-news/nuvalent-nuvl-chief-legal-officer-miller-sells-676k-in-stock-93CH-4435987)[[9]](https://investors.nuvalent.com/index.php?s=159)
View full insider profile →
